HSPA5 and breast carcinoma: Due to its importance as a master regulator in the endoplasmic reticulum it is not surprising that BiP overexpression has been linked to breast cancer progression, as it allows proliferation, angiogenesis, and impacts the response to anticancer therapy [6,15,16,17,18,19,20].